Pronova, Teva decide to terminate US litigation case - Pharmaceutical Business Review

Pronova BioPharma Norge and Teva Pharmaceuticals USA have jointly decided to terminate the patent litigation case in the US District Court for the District of Delaware. The lawsuit covers Pronova BioPharma's US patent no 7,732,488, US patent no. 7,678,930 and US patent no. 7,718,698. The patents entitled, 'Pharmaceutical Composition Comprising Low...